Table 2 Univariable regression analysis between VAT measurement methods to metabolic risk factors.
VAT volume (cm3) | VAT area (L2 level, cm2) | VAT area (Umbilicus level, cm2) | ||
---|---|---|---|---|
Triglyceride | Correlation coefficient | 0.309 | 0.379 | 0.337 |
Significance Level P | 0.007 | 0.008 | 0.003 | |
HDL-cholesterol | Correlation coefficient | − 0.335 | − 0.290 | − 0.224 |
Significance Level P | 0.003 | 0.012 | 0.053 | |
Fasting blood glucose | Correlation coefficient | 0.292 | 0.021 | 0.093 |
Significance Level P | 0.011 | 0.856 | 0.427 | |
Systolic blood pressure | Correlation coefficient | 0.035 | − 0.000 | 0.015 |
Significance Level P | 0.771 | 0.998 | 0.900 | |
Diastolic blood pressure | Correlation coefficient | 0.082 | − 0.174 | − 0.073 |
Significance Level P | 0.494 | 0.146 | 0.545 | |
HOMA-IR | Correlation coefficient | 0.469 | 0.019 | − 0.022 |
Significance Level P | < 0.001 | 0.869 | 0.849 | |
QUICKI | Correlation coefficient | − 0.50 | − 0.036 | 0.017 |
Significance Level P | < 0.001 | 0.762 | 0.886 | |
Matsuda index | Correlation coefficient | − 0.415 | 0.000 | 0.052 |
Significance Level P | 0.003 | 0.999 | 0.724 | |
HOMA-β | Correlation coefficient | 0.212 | − 0.046 | − 0.158 |
Significance Level P | 0.067 | 0.696 | 0.176 | |
Insuliogenic index | Correlation coefficient | 0.015 | 0.034 | − 0.010 |
Significance Level P | 0.898 | 0.774 | 0.933 | |
Hepatic steatosis index | Correlation coefficient | 0.438 | 0.166 | 0.155 |
Significance Level P | 0.0001 | 0.167 | 0.197 | |
NAFLD liver fat score | Correlation coefficient | 0.496 | 0.078 | 0.110 |
Significance Level P | < 0.0001 | 0.519 | 0.360 | |
Framinghan steatosis index | Correlation coefficient | 0.531 | 0.440 | 0.413 |
Significance Level P | < 0.0001 | 0.002 | 0.005 |